(Q2)Feb 29, 2024 | (Q1)Nov 30, 2023 | (FY)Aug 31, 2023 | (Q4)Aug 31, 2023 | (Q3)May 31, 2023 | (Q2)Feb 28, 2023 | (Q1)Nov 30, 2022 | (FY)Aug 31, 2022 | (Q4)Aug 31, 2022 | (Q3)May 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 43.01%-94.69K | -150.79%-96.64K | -132.29%-251.09K | 90.28%-11.16K | -792.51%-35.24K | -2,097.96%-166.15K | -481.22%-38.54K | -108.09K | -114.87K | 5.09K |
Net income from continuing operations | -96.44%-131.32K | -165.54%-88.83K | -138.84%-240.48K | -28.69%-93.28K | -386.09%-46.89K | -470.58%-66.85K | -389.02%-33.45K | ---100.69K | ---72.48K | ---9.65K |
Change In working capital | 136.89%36.63K | -53.67%-7.81K | -43.29%-10.62K | 293.72%82.12K | -20.94%11.65K | -595.71%-99.3K | -2,508.06%-5.08K | ---7.41K | ---42.39K | --14.74K |
-Change in receivables | 65.81%-2.91K | ---1.94K | ---1.19K | --8.77K | ---1.44K | ---8.52K | --0 | --0 | --0 | --0 |
-Change in prepaid assets | 122.22%19.73K | ---15.93K | ---7.12K | --56.64K | --25K | ---88.77K | --0 | --0 | --0 | --0 |
-Change in payables and accrued expense | 1,082.06%19.82K | 298.09%10.07K | 68.88%-2.31K | 139.41%16.7K | -180.83%-11.91K | -110.07%-2.02K | -2,508.06%-5.08K | ---7.41K | ---42.39K | --14.74K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 43.01%-94.69K | -150.79%-96.64K | -132.29%-251.09K | 90.28%-11.16K | -792.51%-35.24K | -2,097.96%-166.15K | -481.22%-38.54K | ---108.09K | ---114.87K | --5.09K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 95.21%-8K | 0 | -3,180.08%-170.24K | 0 | -1.44K | -3,120.87%-167.16K | -1.64K | -5.19K | 0 | 0 |
Net PPE purchase and sale | 95.21%-8K | --0 | -3,180.08%-170.24K | --0 | ---1.44K | -3,120.87%-167.16K | ---1.64K | ---5.19K | --0 | --0 |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 95.21%-8K | --0 | -3,180.08%-170.24K | --0 | ---1.44K | -3,120.87%-167.16K | ---1.64K | ---5.19K | --0 | --0 |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 0 | -89.39%55K | 142.89%516.42K | 0 | 0 | -240.98%-2.02K | 518.43K | 212.61K | 191.08K | 20.1K |
Net issuance payments of debt | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
Net common stock issuance | ---- | ---- | 179.57%650K | --0 | ---- | ---- | ---- | --232.5K | --232.5K | --0 |
Proceeds from stock option exercised by employees | --0 | -91.54%55K | ---- | ---- | ---- | --0 | --650K | ---- | ---- | ---- |
Net other financing activities | ---- | ---- | -571.71%-133.58K | --0 | --0 | ---2.02K | ---131.57K | ---19.89K | ---33.92K | --20.1K |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | --0 | -89.39%55K | 142.89%516.42K | --0 | --0 | -240.98%-2.02K | --518.43K | --212.61K | --191.08K | --20.1K |
Net cash flow | ||||||||||
Beginning cash position | -71.09%172.73K | 79.72%214.38K | 497.74%119.29K | 423.61%225.54K | 1,366.37%262.22K | 4,384.05%597.55K | 497.74%119.29K | --19.96K | --43.07K | --17.88K |
Current changes in cash | 69.38%-102.69K | -108.71%-41.64K | -4.27%95.09K | -114.65%-11.16K | -245.59%-36.68K | -7,460.16%-335.33K | 7,313.57%478.26K | --99.33K | --76.21K | --25.19K |
End cash Position | -73.29%70.05K | -71.09%172.73K | 79.72%214.38K | 79.72%214.38K | 423.61%225.54K | 1,366.37%262.22K | 4,384.05%597.55K | --119.29K | --119.29K | --43.07K |
Free cash from | 69.19%-102.69K | -140.56%-96.64K | -271.92%-421.33K | 90.28%-11.16K | -820.71%-36.68K | -10,762.60%-333.31K | -505.93%-40.17K | ---113.28K | ---114.87K | --5.09K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data